Nishimura Y, Maiocco J, Janda G, Nedved A, et al. Clinical outcomes and safety of the immune checkpoint inhibitor rechallenge in Hodgkin lymphoma: an off-trial analysis. Haematologica 2026 Sep 24. doi: 10.3324/haematol.2026.301311.
PMID: 42779340